Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PhRMA, Others Look For Savings In Reduced Drug Interactions

Executive Summary

Reducing the instances of adverse events related to drug-drug interactions is among the options to reduce health care spending presented by both the Pharmaceutical Research and Manufacturers of America and the American Medical Association

You may also be interested in...



Policy Changes In Part D Could Improve Patients’ Rx Adherence, Professor Argues

Former MedPAC member Bruce Stuart offers policy recommendations that would make medication therapy management programs in the Medicare Part D more effective, with the goal of improving medication adherence.

Cost-Cutting Sequel Yields Little Surprise: PhRMA Supports Efficient Medication Use, More Drug Development, Expanded Access

Following up on their pledge to help reduce growing health costs, PhRMA, other health groups provide more specifics to President Obama.

Pharma Share Of Health Reform Cost Savings To Come From Drug Access, Compliance, Personalized Medicine

As stakeholders pledge to reduce health system growth by $2 trillion over 10 years, Rep. Dingell urges support for public plan; Sen. Grassley wants more “concrete” proposals, CBO score.

Related Content

Topics

Latest News
UsernamePublicRestriction

Register

PS051146

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel